VivoSim Labs (VIVS) Net Equity Issued and Repurchased (2010 - 2026)
VivoSim Labs (VIVS) posted Net Equity Issued and Repurchased of $3.0 million for Q1 2026, up 66.5% on a QoQ basis from $1.8 million in Q4 2025, and down 5.9% year-over-year from $3.2 million in Q1 2025.
Analysis
VivoSim Labs (VIVS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Net Equity Issued and Repurchased for 12 years, with the latest figure at $3.0 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased fell 5.9% year-over-year to $3.0 million in Q1 2026; TTM through Jun 2026 was $6.6 million, a 39.62% increase from a year earlier, with the FY2026 full-year figure at $4.8 million, down 45.65% from the prior year.
- Net Equity Issued and Repurchased was $3.0 million for Q1 2026 at VivoSim Labs, up from $1.8 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $6.2 million in Q2 2024, with the low at -$371000.0 in Q3 2024.
- Average Net Equity Issued and Repurchased over 4 years is $1.9 million, with a median of $1.8 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased sank 91.47% in 2024, then jumped 1700.0% in 2025.
- Over 4 years, Net Equity Issued and Repurchased stood at $1.2 million in 2023, then tumbled by 91.47% to $100000.0 in 2024, then surged by 1700.0% to $1.8 million in 2025, then jumped by 66.5% to $3.0 million in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $3.0 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | -371,000.00 |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 264,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Jun 30, 2021 | 251,000.00 |
| Mar 31, 2021 | 20.75 Mn |
| Dec 31, 2020 | 3.04 Mn |
| Jun 30, 2019 | 5.00 Mn |
| Mar 31, 2019 | 6.43 Mn |
| Dec 31, 2018 | 1.80 Mn |
| Sep 30, 2018 | 4.90 Mn |
| Jun 30, 2018 | 3.00 Mn |
| Mar 31, 2018 | 2.28 Mn |
| Dec 31, 2017 | 3.10 Mn |